Financial Daily from THE HINDU group of publications
Tuesday, Mar 09, 2004

News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - Announcements


Morepen gets USFDA nod for Himachal facility

Our Bureau

New Delhi , March 8

MOREPEN Labs Ltd has received a fresh US Food and Drug Administrator approval for its active pharmaceutical ingredient (API) manufacturing facilities at Masulkhana, Himachal Pradesh.

The facility is currently manufacturing anti-histamine drug Loratadine for which it had received an approval by the FDA in March 1999. According to a company statement, the inspection for the current approval was the first after the drug went off patent in December 2002 and commencement of supplies.

"The fresh USFDA approval comes at a time when the company is consolidating its operations and further planning to boost its turnaround efforts. The debt restructuring talks with the bankers are also at an advanced stage of consideration," said Mr Sushil Suri, Chairman and Managing Director, Morepen Laboratories. The company has regular supply contracts with companies such as Novartis and Merck.

To leverage on the USFDA approved infrastructure at Masulkhana, Morepen has added two more products to the facilities. These two molecules, Citalopram and Sertraline, are anti-depressant drugs that command a combined market size of $4.25 billion (Rs 19,125 crore). The Drug Master Files (DMFs) for them are expected to be filed in the next six months.

More Stories on : Announcements | Pharmaceuticals | Standards & Benchmarks

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Morepen gets USFDA nod for Himachal facility


Israel's Hamlet plans industrial park
Indo Gulf Fertilisers unit shut-down
Boston Scientific gets US nod for coronary stent
Hindustan Inks is now Micro Inks
Siyaram interim Rs 4
Alok Ind plans to hike share capital
Merven to allot warrants to ICICI venture fund
Avon Organics to allot warrants to promoters
Tata Motors to raise up to $500 m through issue of securities
Kerala HC declines to stay Govt order on Coke
Nicholas Piramal gets approval for Canere merger
KSE draws up expansion plan; to set up veg refining plant
IOC eyes Gujarat, Haryana for naphtha cracker plant
Tyco Elec to make refractive plate switch at Bangalore
HPCL inks product sharing agreement with Shell India
GAIL issue proves sceptics wrong: CMD
Berger Paints EGM okays 1:2 bonus
Ten Sports expects rise in subscription declaration
Adesh Gupta new Liberty Shoes CEO
Bhilai Steel posts 15 pc rise in output
Talaulicar to oversee Cummins operations



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line